GLB1 and hepatocellular carcinoma: After genotyping 386 Korean HCC cases and 587 Korean controls with the Affymetrix SNP6.0 assay, they found that the 3p21.33 GLB1 rs4678680 G > T polymorphism is most significantly associated with HCC risk (odds ratio [OR] = 2.27, 95% confidence intervals [CI] = 1.68–3.08, P = 6 × 10−7).